SCHEMBL7237675

SCHEMBL7237675

CC(=O)N[C@@H](CC(C)C)[C@@H]1O[C@@H](C(=O)OC(C)(C)C)C[C@H]1C(=O)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7230216 0.88 HTT (0.32) —
SCHEMBL7848573 0.88 HTT (0.32) —
SCHEMBL7239010 0.78 CYP1A2 (0.35) —
SCHEMBL7853547 0.78 CYP1A2 (0.35) —
SCHEMBL7241105 0.76 HTT (0.39) —
SCHEMBL7240247 0.76 HTT (0.39) —
SCHEMBL6697196 0.74 CHRM2 (0.33) —
SCHEMBL4321037 0.74 CYP1A2 (0.36) —
SCHEMBL7230115 0.74 CYP1A2 (0.36) —
SCHEMBL7829651 0.73 ALDH1A1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518305-B1 For inhibiting neuraminidases from disease- causing microorganisms, especially, influenza neuraminidase ABBOTT LABORATORIES 2003-02-11 — — US disclosed
WO-2001028979-A2 INHIBITORS OF NEURAMINIDASES ABBOTT LABORATORIES (US) 2001-04-26 — — WO disclosed
Send feedback